Lupin gains after launch of new drug for treatment of heart disease in Canada
Lupin Limited has also received approval from the United States Food and Drug Administration (USFDA) for its Abbreviated New Drug Application for Pirfenidone Capsules, 267 mg. Lupin will manufacture its Pirfenidone Capsules at its Pithampur facility in India.
Lupin has also received USFDA approval for Pirfenidone Capsules.